We read with interest the recent report by Giebel et al,[1][1] who showed a dramatic effect of KIR ligand incompatibility on survival and transplant-related mortality in a heterogeneous patient population after allogeneic hematopoietic stem cell transplantation using unrelated donors. The authors
No takes yet. Share an insight, caveat, or question.
Bornhäuser et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: